Refining frontotemporal dementia with parkinsonism linked to chromosome 17: introducing FTDP-17 (MAPT) and FTDP-17 (PGRN).

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Archives of Neurology

• Publication date

  2008-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1001/archneur.65.4.460PMID 18413467PMCID PMC2746630
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Prominent phenotypic variability associated with mutations in Progranulin.

  2009cited by this paper
• A novel deletion in progranulin gene is associated with FTDP-17 and CBS.

  2008cited by this paper
• Progranulin and tau gene mutations both as cause for dementia: 17q21 finally defined.

  2007cited by this paper
• Clinicopathologic features of frontotemporal dementia with Progranulin sequence variation

  2007cited by this paper
• Neuropathologic Features of Frontotemporal Lobar Degeneration With Ubiquitin-Positive Inclusions With Progranulin Gene (PGRN) Mutations

  2007cited by this paper
• Progranulin mutations in primary progressive aphasia: the PPA1 and PPA3 families.

  2007cited by this paper
• Impact of apolipoprotein gene on cognitive impairment and recovery after traumatic brain injury

  2007cited by this paper
• The neuropathology of frontotemporal lobar degeneration caused by mutations in the progranulin gene.

  2006cited by this paper
• Characteristics of frontotemporal dementia patients with a Progranulin mutation

  2006cited by this paper
• HDDD2 is a familial frontotemporal lobar degeneration with ubiquitin‐positive, tau‐negative inclusions caused by a missense mutation in the signal peptide of progranulin

  2006cited by this paper
• A family with tau-negative frontotemporal dementia and neuronal intranuclear inclusions linked to chromosome 17.

  2006cited by this paper
• Mutations in progranulin are a major cause of ubiquitin-positive frontotemporal lobar degeneration.

  2006influential reference
• Novel splicing mutation in the progranulin gene causing familial corticobasal syndrome.

  2006cited by this paper
• Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17

  2006cited by this paper
• Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21

  2006cited by this paper
• Progranulin gene mutations associated with frontotemporal dementia and progressive non-fluent aphasia.

  2006cited by this paper
• Mutations in progranulin explain atypical phenotypes with variants in MAPT.

  2006cited by this paper
• Frontotemporal dementia and parkinsonism associated with the IVS1+1G->A mutation in progranulin: a clinicopathologic study.

  2006cited by this paper
• Ubiquitinated TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis

  2006cited by this paper
• A Belgian ancestral haplotype harbours a highly prevalent mutation for 17q21-linked tau-negative FTLD.

  2006cited by this paper
• Inhibition of glycogen synthase kinase-3 by lithium correlates with reduced tauopathy and degeneration in vivo.

  2005cited by this paper
• Longitudinal characterization of two siblings with frontotemporal dementia and parkinsonism linked to chromosome 17 associated with the S305N tau mutation.

  2005cited by this paper
• Microtubule-binding drugs offset tau sequestration by stabilizing microtubules and reversing fast axonal transport deficits in a tauopathy model.

  2005cited by this paper
• Pick's complex and FTDP‐17

  2003cited by this paper
• Familial Primary Progressive Aphasia

  2003cited by this paper
• Tau negative frontal lobe dementia at 17q21: significant finemapping of the candidate region to a 4.8 cM interval

  2002cited by this paper
• Corticobasal Degeneration and Frontotemporal Dementia Presentations in a Kindred with Nonspecific Histopathology

  2002cited by this paper
• Frequency of tau gene mutations in familial and sporadic cases of non-Alzheimer dementia.

  2001cited by this paper
• Hereditary dysphasic disinhibition dementia A frontotemporal dementia linked to 17 q21‐‐22

  1998cited by this paper
• Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17

  1998cited by this paper
• Frontotemporal dementia and parkinsonism linked to chromosome 17: A consensus conference

  1997cited by this paper

• Pyrimidine RNA Homopolymers Promote Amyloid Formation of a Tau Fragment from the Microtubule-Binding Domain.

  2026cites this paper
• Tau and tauopathies across primate species: implications for modeling neurodegenerative disorders

  2025cites this paper
• DICER1 Syndrome: What Do We Know of the Pathogenetic Mechanisms?

  2025cites this paper
• Biomolecular phase separation of microtubule-associated protein Tau and its role in the genesis of Brain Disorders.

  2025cites this paper
• Atypical Parkinsonian Disorders.

  2025cites this paper
• Behavioral variant frontotemporal dementia with pathogenic variant in MAPT presenting as dementia with Lewy body disease

  2024cites this paper
• Effects of P301L-TAU on post-translational modifications of microtubules in human iPSC-derived cortical neurons and TAU transgenic mice

  2024cites this paper
• Influence of FTDP-17 mutants on circular tau RNAs.

  2024cites this paper
• A network-based systems genetics framework identifies pathobiology and drug repurposing in Parkinson’s disease

  2024cites this paper
• Are we missing early-onset frontotemporal dementia as late-onset primary psychiatric disorder? A case series

  2024cites this paper
• Frontotemporal Dementia

  2024cites this paper
• Influence of FTDP-17 mutants on circular Tau RNAs

  2023cites this paper
• The tauopathies.

  2023cites this paper
• Genotype–Phenotype Correlation in Progressive Supranuclear Palsy Syndromes: Clinical and Radiological Similarities and Specificities

  2022cites this paper
• Therapeutic modulation of gene expression in the disease state: Treatment strategies and approaches for the development of next-generation of the epigenetic drugs

  2022cites this paper
• Alterations of Striatal Subregions in a Prion Protein Gene V180I Mutation Carrier Presented as Frontotemporal Dementia With Parkinsonism

  2022cites this paper
• Application of CRISPR-Cas systems in neuroscience.

  2021cites this paper
• CRISPR-Cas Gene Perturbation and Editing in Human Induced Pluripotent Stem Cells

  2021cites this paper
• Progressive Supranuclear Palsy and Corticobasal Degeneration.

  2021cites this paper
• Parkin beyond Parkinson’s Disease—A Functional Meaning of Parkin Downregulation in TDP-43 Proteinopathies

  2021cites this paper
• The Role of White Matter Dysfunction and Leukoencephalopathy/Leukodystrophy Genes in the Aetiology of Frontotemporal Dementias: Implications for Novel Approaches to Therapeutics

  2021cites this paper
• Mood and emotional disorders associated with parkinsonism, Huntington disease, and other movement disorders.

  2021cites this paper
• Genome Editing in iPSC-Based Neural Systems: From Disease Models to Future Therapeutic Strategies

  2021cites this paper
• Editorial: Back to the Future: On the Road Towards Precision Psychiatry

  2020cites this paper
• [Genetic Diversity in Frontotemporal Dementia].

  2020cites this paper
• Progressive supranuclear palsy: Advances in diagnosis and management.

  2020influential citation
• The application of in vitro‐derived human neurons in neurodegenerative disease modeling

  2020cites this paper
• Genetic Diversity in Frontotemporal Dementia

  2020cites this paper
• Genetic Risk Factors for Essential Tremor: A Review

  2020cites this paper
• Neurotherapeutic effect of Hyptis spp. leaf extracts in Caenorhabditis elegans models of tauopathy and polyglutamine disease: role of the glutathione redox cycle.

  2020cites this paper
• PET Neuroimaging in Dementia Conditions

  2020cites this paper
• Genetically Engineering the Nervous System with CRISPR-Cas

  2020cites this paper
• Genetic mimics of the non-genetic atypical parkinsonian disorders - the 'atypical' atypical.

  2019cites this paper
• Overlapping genetic architecture between Parkinson disease and melanoma

  2019influential citation
• Frontotemporal dementia.

  2019cites this paper
• Language impairment in primary progressive aphasia and other neurodegenerative diseases

  2019cites this paper
• 10 Frontotemporal Lobar Degeneration

  2019cites this paper
• Precision Medicine for Frontotemporal Dementia

  2019cites this paper
• LRRK2, alpha-synuclein, and tau: partners in crime or unfortunate bystanders?

  2019cites this paper
• Neurochemical Aspects of Frontotemporal Dementia

  2019cites this paper
• Cognitive Indicators of Preclinical Behavioral Variant Frontotemporal Dementia in MAPT Carriers

  2018cites this paper
• Analysis of frontotemporal dementia, amyotrophic lateral sclerosis, and other dementia-related genes in 107 Korean patients with frontotemporal dementia.

  2018cites this paper
• Sleep Architecture Changed Without RBD in Patients With FTDP-17

  2018cites this paper
• White matter tauopathy: Transient functional loss and novel myelin remodeling

  2018cites this paper
• Frontotemporal dementia: latest evidence and clinical implications

  2018cites this paper
• Transcriptome Engineering with RNA-Targeting Type VI-D CRISPR Effectors.

  2018cites this paper
• Running title : White matter tauopathy

  2018cites this paper
• 11C-CFT-PET in Presymptomatic FTDP-17: A Potential Biomarker Predicting Onset

  2017cites this paper
• Tau protein in neurodegenerative diseases - a review.

  2017cites this paper
• The Leukocentric Theory of Neurological Disorder: A Manifesto

  2017cites this paper
• Genetic Features of MAPT, GRN, C9orf72 and CHCHD10 Gene Mutations in Chinese Patients with Frontotemporal Dementia.

  2017cites this paper
• NEURODEGENERATIVE DISORDERS

  2017cites this paper
• Genetic approaches to neurodegenerative disease

  2016cites this paper
• Frontotemporal Dementia.

  2016influential citation
• Parkinsonism, movement disorders and genetics in frontotemporal dementia

  2016cites this paper
• Cellular Physiology and Cell-to-Cell Propagation of Tau in Neurodegeneration : The Impact of Late-Onset Alzheimer's Disease Susceptibility Genes

  2016cites this paper
• Novel GRN Mutations in Patients with Corticobasal Syndrome

  2016cites this paper
• The Evolution of TP53 Mutations: From Loss-of-Function to Separation-of-Function Mutants.

  2016cites this paper
• Expression of A152T human tau causes age‐dependent neuronal dysfunction and loss in transgenic mice

  2016cites this paper
• Pathogenesis and treatment of frontotemporal lobe degeneration

  2015cites this paper
• Genetics of Atypical Parkinsonism

  2015cites this paper
• Motor neuron disease-frontotemporal dementia: a clinical continuum

  2015cites this paper
• Diagnostyka neuropsychologiczna w atypowych zespołach parkinsonowskich

  2015influential citation
• Clinical features of TBK1 carriers compared with C9orf72, GRN and non-mutation carriers in a Belgian cohort

  2015influential citation
• Sex hormone-related neurosteroids differentially rescue bioenergetic deficits induced by amyloid-β or hyperphosphorylated tau protein

  2015cites this paper
• Invited review: Frontotemporal dementia caused by microtubule-associated protein tau gene (MAPT) mutations: a chameleon for neuropathology and neuroimaging

  2015cites this paper
• Atypical parkinsonism: diagnosis and treatment.

  2015cites this paper
• Agraphia in patients with frontotemporal dementia and parkinsonism linked to chromosome 17 with P301L MAPT mutation: dysexecutive, aphasic, apraxic or spatial phenomenon?

  2014cites this paper
• Sample Application for Small Business Funding

  2014influential citation
• Parkinsonian syndrome in familial frontotemporal dementia.

  2014influential citation
• Parkinson's disease: chameleons and mimics

  2014cites this paper
• Annonacin, a natural lipophilic mitochondrial complex I inhibitor, increases phosphorylation of tau in the brain of FTDP-17 transgenic mice.

  2014cites this paper
• Frontotemporal Lobar Degeneration: A Clinical Approach

  2014cites this paper
• Histone deacetylase 6 inhibition improves memory and reduces total tau levels in a mouse model of tau deposition

  2014cites this paper
• Subcortical and Deep Cortical Atrophy in Frontotemporal Dementia due to Granulin Mutations

  2014cites this paper
• Elevated Expression of Secreted Autocrine Growth Factor Progranulin Increases Cervical Cancer Growth

  2014cites this paper
• Clinical and genetic analysis of MAPT, GRN, and C9orf72 genes in Korean patients with frontotemporal dementia.

  2014influential citation
• Movement Disorders in Frontotemporal Dementia

  2014cites this paper
• Natural selection increases mutational robustness in complex diseases: Mendelian evidence from early versus late onset common diseases

  2013cites this paper
• New Perspective on Parkinsonism in Frontotemporal

  2013cites this paper
• The role of exogenous DJ-1 in neuroprotection

  2013cites this paper
• Progranulin gene (GRN) promoter methylation is increased in patients with sporadic frontotemporal lobar degeneration

  2013cites this paper
• New Perspective on Parkinsonism in Frontotemporal Lobar Degeneration

  2013cites this paper
• “Atypical” atypical parkinsonism: New genetic conditions presenting with features of progressive supranuclear palsy, corticobasal degeneration, or multiple system atrophy—A diagnostic guide

  2013cites this paper
• Analyses of the MAPT, PGRN, and C9orf72 mutations in Japanese patients with FTLD, PSP, and CBS.

  2013cites this paper
• Magnetic resonance spectroscopy in common dementias.

  2013cites this paper
• Progranulin Gene Variability and Plasma Levels in Bipolar Disorder and Schizophrenia

  2012cites this paper
• Pallidopontonigral degeneration: A deceptive familial tauopathy

  2012cites this paper
• Genetics of Familial Amyotrophic Lateral Sclerosis

  2012cites this paper
• Evolution of neurodegeneration.

  2012cites this paper
• Clinical phenotypes and genetic biomarkers of FTLD

  2012cites this paper
• Role of tau protein in neuronal damage in Alzheimer's disease and Down syndrome.

  2012cites this paper
• Frontotemporal lobar degeneration: current knowledge and future challenges

  2012cites this paper
• Insulin and IGF-1 signalling: longevity, protein homoeostasis and Alzheimer's disease.

  2012cites this paper
• Genetic contributors to frontotemporal lobar degeneration: beyond monogenic disease.

  2011cites this paper
• Synchronicity of the EEG signal: a marker of brain dysfunction in patients with psychogenic non-epileptic seizures?

  2011cites this paper
• Intra-Familial Clinical Heterogeneity due to FTLD-U with TDP-43 Proteinopathy Caused by a Novel Deletion in Progranulin Gene (PGRN)

  2011cites this paper
• Phenotypic Heterogeneity of the GRN Asp22fs Mutation in a Large Italian Kindred

  2011cites this paper
• Serum vitamin B12 and folate levels in Parkinson's disease patients treated with duodenal levodopa infusion

  2011influential citation
• Chromosome 17 in FTLD: from MAPT tau to progranulin and back.

  2011cites this paper